Riskpilot← Back to searchSign inGet full accessØSTFOLD HUDLEGEKLINIKK AS
ASActiveOrg 914582229Tordenskiolds Gate 12, 1606 FredrikstadMedical specialists activities · NACE 8622Est. 20144 employees
Revenue 2024
NOK 7,2M
+3% vs 2023
EBITDA margin
40.2%
+4% vs 2023
Equity ratio
1.7%
Financial strength
Net profit 2024
NOK 2,3M
+2% vs 2023
| Revenue | NOK 7,2M | +3% |
| EBITDA | NOK 2,9M | +4% |
| Net profit | NOK 2,3M | +2% |
| Total assets | NOK 3,6M | +5% |
| Equity | NOK 61K | -70% |
| Employees | 4 | — |
Legal name
ØSTFOLD HUDLEGEKLINIKK AS
Org number
914582229
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
8. desember 2014
Share capital
NOK 30 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Hudlegevirksomhet, levering av legetjenester innen spesialiteten hud- og veneriske sykdommer, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Tordenskiolds Gate 12, 1606 Fredrikstad
Phone
+4740646000
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 055 | 4 588 | 6 358 | 6 985 | 7 169 |
| Staff expenses | −2 260 | −2 262 | −2 560 | −2 735 | −2 965 |
| EBITDA | 1 316 | 1 068 | 2 465 | 2 766 | 2 880 |
| Depreciation & amort. | −469 | −215 | −71 | −83 | −83 |
| EBIT | 847 | 854 | 2 394 | 2 682 | 2 797 |
| Net financials | −12 | −1 | 4 | 30 | 98 |
| Profit before tax | 835 | 853 | 2 398 | 2 713 | 2 895 |
| Tax | 245 | 192 | 502 | 503 | 637 |
| Net profit | 590 | 661 | 1 896 | 2 209 | 2 258 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 969 | 1 257 | 2 970 | 3 478 | 3 634 |
| Equity | 636 | 97 | 493 | 203 | 61 |
| Long-term debt | 95 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 237 | 1 160 | 2 477 | 3 275 | 3 574 |
| Total debt | 1 332 | 1 160 | 2 477 | 3 275 | 3 574 |
EBITDA margin
40.2%
This company
15.8%
Market median
+154% vs market
20202024
Equity ratio
1.7%
This company
38.2%
Market median
-96% vs market
20202024
Return on equity
3722.9%
This company
18.4%
Market median
+20133% vs market
20202024
Net profit margin
31.5%
This company
8.1%
Market median
+289% vs market
20202024
Asset turnover
1.97×
This company
1.12×
Market median
+76% vs market
20202024
Debt / equity
58.92×
This company
0.62×
Market median
-9403% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GE Chief Executive Officer | Chief Executive Officer | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2014 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ØSTFOLD HUDLEGEKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Guttorm Edvin Guleng | Chief Executive Officer | 0 companies |
| Anja Dyresen Guleng | Board of Directors | 0 companies |